Homebest biotech stocks

best biotech stocks

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO

January 2, 2021

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages NK, PRGX, CBLI, and IPHI Shareholders to Contact the Firm

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages NK, PRGX, CBLI, and IPHI Shareholders to Contact the Firm

January 2, 2021

Aravive Announces Board Member Transition to Advisory Role

Aravive Announces Board Member Transition to Advisory Role

December 31, 2020

FBIO LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fortress Biotech, Inc. Investors with Losses over $100K to Seek Counsel Before Important January 26 Deadline in Securities Class Action – FBIO

FBIO LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fortress Biotech, Inc. Investors with Losses over $100K to Seek Counsel Before Important January 26 Deadline in Securities Class Action – FBIO

December 31, 2020

Anavex Life Sciences (AVXL) Upgraded to Buy: Here’s Why

Anavex Life Sciences (AVXL) Upgraded to Buy: Here’s Why

December 31, 2020

FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021

FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021

December 31, 2020

Altimmune (ALT) Begins Phase II Study for Chronic Hepatitis B

Altimmune (ALT) Begins Phase II Study for Chronic Hepatitis B

December 31, 2020

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

December 31, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

December 30, 2020

Aeglea (AGLE) Upgraded to Buy: Here’s Why

Aeglea (AGLE) Upgraded to Buy: Here’s Why

December 30, 2020

« 1 … 535 536 537 538 539 … 557 »